CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING PRODUCT DEVELOPMENT CAPACITY
CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING…
October 28, 2019/by Studio 98Biotech Stock On The Radar: Aimmune Awaits Adcom Test
September 12, 2019/by Studio 98CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment
Clearwater, Florida, May 14, 2019 — CoreRx, Inc. today announced
that…
May 13, 2019/by michelle hallthat…
CORERX, INC. ADDS INCREASING PRODUCT DEVELOPMENT CAPACITY Company to Continue Investments, Increase Workforce
March 17, 2019/by michelle hallCoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI® (Clobazam)
Clearwater, Florida- November 4, 2018 - CoreRx, Inc. announces…
November 2, 2018/by michelle hallInstallation of the Optel Line Master Serialization and Aggregation
Clearwater, Florida – As part of CoreRx, Inc’s growth in…
October 23, 2018/by michelle hallLocation
14205 Myerlake Circle
Clearwater, FL 33760 USA
Contact Us
Phone: 727.259.6950
Toll Free: 877.461.4448
Fax: 727.683.9530